Business

Templum to Offer Premier Private Market Investment Opportunities in Perplexity AI, OpenAI, and Colossal Biosciences to SoFi Members

Templum, a leading infrastructure provider for private markets and SoFi (NASDAQ: SOFI), the one-stop shop for digital financial services, today announced the launch of a limited-time private market investment window for accredited investors to access Colossal Biosciences, OpenAI, and/or Perplexity AI through the Cosmos Fund.

articleSofi Technologies, Inc.March 5, 20263/company/sofi-technologies-inc/news/templum-to-offer-premier-private-market-investment-opportunities-in-perplexity-ai-openai-and-colossal-biosciences-to-sofi-members-11
Templum to Offer Premier Private Market Investment Opportunities in Perplexity AI, OpenAI, and Colossal Biosciences to SoFi Members

About this update from Sofi Technologies, Inc.

[{"type":"text","content":"Limited-time offering provides investors access to highly sought-after private market leaders","length":93,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, March 5, 2026 /PRNewswire/ -- Templum, a leading infrastructure provider for private markets and SoFi (NASDAQ: SOFI), the one-stop shop for digital financial services, today announced the launch of a limited-time private market investment window for accredited investors to access Colossal Biosciences, OpenAI, and/or Perplexity AI through the Cosmos Fund.","length":386,"tagName":"p"},{"type":"image","alt":"Templum is making investing in private markets as easy as public markets. (PRNewsfoto/Templum Inc.)","displaySize":"","headline":null,"caption":"Templum is making investing in private markets as easy as public markets. (PRNewsfoto/Templum Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":53,"url":"https://media.zenfs.com/en/prnewswire.com/b3bf0074c391d51ccb80e84922bbb6d3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/SDJy23MQ5BsoIyTBdrW8YA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTkzO2NmPXdlYnA-/https://media.zenfs.com/en/prnewswire.com/b3bf0074c391d51ccb80e84922bbb6d3","width":400,"height":53}},"href":"https://mma.prnewswire.com/media/2261632/Templum_Primary_logo_YEL_BLK1_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The three offerings will be available from March 5 through March 30, 2026, and represent the latest opportunities from the Cosmos Fund, which is designed to provide differentiated access to category-defining private companies for qualified investors.","length":285,"tagName":"p"},{"type":"text","content":"OpenAI, Perplexity AI, and Colossal Biosciences – pioneers in their respective digital and biological markets – are redefining what's possible today across their sectors.","length":174,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Colossal Biosciences is pursuing a proprietary biotech platform with applications spanning de-extinction, species preservation, livestock optimization, climate science, and human therapeutics. The company's latest report states that it has achieved decacorn status, with backing from investors including TWG Global and other...

More updates from Sofi Technologies, Inc.

TemplumPerplexity AIaccredited investorsColossal Biosciencesprivate marketsinvestment productsfinancial servicesinvestmentSoFicapital markets